Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for FOSRENOL
- Different Effects of Non-calcium Phosphate Binders on Serum Calcium
- Lanthanum Carbonate (Fosrenol®) to Reduce Oxalate Excretion in Patients With Secondary Hyperoxaluria and Nephrolithiasis
- Healthy Combine Study
- A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP1517 and Lanthanum Carbonate Hydrate
- Phophate Lowering Trial
- Fosrenol Post-marketing Surveillance in Japan
- The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23
- A Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Investigate and Compare the Efficacy, Safety and Tolerability of Lanthanum Carbonate With Calcium Carbonate in Hyperphosphataemic Children and Adolescents With Chronic Kidney Disease on
- Fosrenol and Phosphorus Balance - Lanthanum Carbonate
- Fosrenol Post-marketing Surveillance for Hemodialysis in Japan
- Fosrenol Post-marketing Surveillance for Continuous Cyclic Peritoneal Dialysis in Japan
- Circadian Rhythm Modulation by Dietary Phosphorus in Chronic Kidney Disease
- Efficacy of Lanthanum Carbonate in Calciphylaxis
- Bioequivalence Study of BAY77-1931 Granule
- The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 ( FGF23) in Chronic Kidney Disease
- The Pharmacokinetics of Rocaltrol When Administered Alone or in Combination With Fosrenol or Renvela in Healthy Volunteers
- Pharmacodynamic Study of Two Lanthanum Carbonate Formulations in Healthy Adults
- Comparing Absorption of Dietary Phosphorus When Administering FOSRENOL® or RENVELA® in Healthy Adult Volunteers
- Fibroblast Growth Factor-23 (FGF23) Reduction in Predialysis Chronic Kidney Disease (CKD)
- Phase III Study to Investigate the Safety and Efficacy of Fermagate and Lanthanum Carbonate
- A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD
- Chewed vs. Crushed Lanthanum Carbonate in Hemodialysis Patients
- Long-term Effect of Lanthanum Carbonate on Bone
- Conversion From Standard Phosphate Binder Therapy to Fosrenol® (Lanthanum Carbonate) in Chronic Kidney Disease Stage 5
- Head to Head Study Against Sevelamer Hydrochloride
- Efficacy and Safety of Lanthanum Carbonate in Reducing Serum Phosphorus Levels in Subjects With Stage 3 and 4 Chronic Kidney Disease
- Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Disease
Clinical trials list
click for details